USFDA carries out surprise inspection at Sun Pharma's Dadra plant
Friday, April 7, 2017, 7:13 PM
The US Food and Drugs Administration is conducting a surprise inspection of Sun Pharma's Dadra plant to check compliance of current good manufacturing practices. Dadra plant is the drug maker's second most important facility serving the US market after Halol. The company stock dipped 3% on Friday on reports of inspection. The US market accounts for about half of the drug maker's consolidated revenue.